TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Daito Pharmaceutical Co., Ltd. ( (JP:4577) ) has issued an update.
Daito Pharmaceutical Co., Ltd. reported a 2.6% increase in net sales for the three months ended August 31, 2025, compared to the same period last year. The company also saw significant improvements in operating profit and profit attributable to owners of the parent, with increases of 17.6% and 12.8% respectively. These results reflect a positive financial trajectory and suggest a strengthening position within the industry, despite the exclusion of Daiwa Pharmaceutical Co., Ltd. from consolidation due to a merger.
The most recent analyst rating on (JP:4577) stock is a Hold with a Yen1261.00 price target. To see the full list of analyst forecasts on Daito Pharmaceutical Co., Ltd. stock, see the JP:4577 Stock Forecast page.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating within the pharmaceutical industry. The company is primarily focused on the development, manufacturing, and distribution of pharmaceutical products.
Average Trading Volume: 72,427
Technical Sentiment Signal: Buy
Current Market Cap: Yen35.93B
For detailed information about 4577 stock, go to TipRanks’ Stock Analysis page.